Back to Browse Journals » Vascular Health and Risk Management » Volume 8

Very low levels of HDL cholesterol and atherosclerosis, a variable relationship – a review of LCAT deficiency

Authors Savel J, Lafitte M, Pucheu Y, Pradeau V, Tabarin A, Couffinhal T

Published Date June 2012 Volume 2012:8 Pages 357—361

DOI http://dx.doi.org/10.2147/VHRM.S29985

Received 16 January 2012, Accepted 17 February 2012, Published 5 June 2012

Julia Savel,1,2 Marianne Lafitte,1 Yann Pucheu,1,3 Vincent Pradeau,1 Antoine Tabarin,2,3 Thierry Couffinhal1,3,4
1Centre d'Exploration, de Prévention et de Traitement de l'Athérosclérose, Hôpital Cardiologique, 2Service d'endocrinologie, CHU Bordeaux, Université Bordeaux Segalen, Bordeaux, France; 3Université de Bordeaux Adaptation cardiovasculaire à l'ischémie, 4INSERM, Adaptation cardiovasculaire à l'ischémie, U1034, Pessac, France

Abstract: A number of epidemiological and clinical studies have demonstrated that plasma high-density lipoprotein (HDL) level is a strong inverse predictor of cardiovascular events. HDL is believed to retard the formation of atherosclerotic lesions by removing excess cholesterol from cells and preventing endothelial dysfunction. Lecithin cholesterol acyltransferase (LCAT) plays a central role in the formation and maturation of HDL, and in the intravascular stage of reverse cholesterol transport: a major mechanism by which HDL modulates the development and progression of atherosclerosis. A defect in LCAT function would be expected to enhance atherosclerosis, by interfering with the reverse cholesterol transport step. As such, one would expect to find more atherosclerosis and cardiovascular events in LCAT-deficient patients. But this relationship is not always evident. In this review, we describe contradictory reports in the literature about cardiovascular risks in this patient population. We discuss the paradoxical finding of severe HDL deficiency and an absence of subclinical atherosclerosis in LCAT-deficient patients, which has been used to reject the hypothesis that HDL level is important in the protection against atherosclerosis. Furthermore, to illustrate this paradoxical finding, we present a case study of one patient, referred for evaluation of global cardiovascular risk in the presence of a low HDL cholesterol level, who was diagnosed with LCAT gene mutations.

Keywords: atherosclerosis, LCAT function, cardiovascular risk, high-density lipoprotein

Download Article [PDF] View Full Text [HTML] 

Creative Commons License This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution - Non Commercial (unported, v3.0) License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at: http://www.dovepress.com/permissions.php

Readers of this article also read:

Cardiac allograft immune activation: current perspectives

Chang D, Kobashigawa J

Transplant Research and Risk Management 2015, 7:13-22

Published Date: 18 December 2014

Ex vivo and in vivo evaluation of an ultrasonic device for precise dissection, coagulation, and transection

Bertke BD, Scoggins PJ, Welling AL, Widenhouse TV, Chen C, Kallakuri S, Cavanaugh JM, Clymer JW, Amaral JF

Open Access Surgery 2015, 8:1-7

Published Date: 18 December 2014

Renal interstitial fibrosis induced by high-dose mesoporous silica nanoparticles via the NF-κB signaling pathway

Chen X, Zhouhua W, Jie Z, Xinlu F, Jinqiang L, Yuwen Q, Zhiying H

International Journal of Nanomedicine 2015, 10:1-22

Published Date: 18 December 2014

Transmyocardial revascularization devices: technology update

Kindzelski BA, Zhou Y, Horvath KA

Medical Devices: Evidence and Research 2015, 8:11-19

Published Date: 18 December 2014

Prostate stem cell antigen-targeted nanoparticles with dual functional properties: in vivo imaging and cancer chemotherapy

Gao X, Luo Y, Wang Y, Pang J, Liao C, Lu H, Fang Y

International Journal of Nanomedicine 2012, 7:4037-4051

Published Date: 30 July 2012

Engineering of silicon surfaces at the micro- and nanoscales for cell adhesion and migration control

Torres-Costa V, Martínez-Muñoz G, Sánchez-Vaquero V, Muñoz-Noval A, González-Méndez L, Punzón-Quijorna E, Gallach-Pérez D, Manso-Silván M, Climent-Font A, García-Ruiz JP, Martín-Palma RJ

International Journal of Nanomedicine 2012, 7:623-630

Published Date: 3 February 2012

Potentials and limitations of microorganisms as renal failure biotherapeutics

Poonam Jain, Sapna Shah, Razek Coussa, Satya Prakash

Biologics: Targets and Therapy 2009, 3:233-243

Published Date: 18 May 2009

Nanoparticulate carriers for the treatment of coronary restenosis

Luis Brito, Mansoor Amiji

International Journal of Nanomedicine 2007, 2:143-161

Published Date: 16 August 2007